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The diterpene ester promoter of mouse skin tumors, 12-0-tetradecanoyl-
phorbol-13-acetate, induced a DNase activity in the Epstein-Barr virus-producer
cell line P3HR-1. The elution patterns of the enzyme from DEAE-cellulose,
phosphocellulose, and DNA-cellulose columns were different from virus-associat-
ed DNA polymerase activity. The partially purified activity could be neutralized
to the extent of 90%o by sera of patients with nasopharyngeal carcinoma. Purified
immunoglobulin G from sera of nasopharyngeal carcinoma patients inhibited this
enzyme and that obtained from superinfected Raji cells to the same extent. The
partially purified enzyme preferred native DNA as a substrate over denatured
DNA and 3'-terminally labeled activated calf thymus DNA. The activity was
inhibited by high ionic strength. Phosphonoformic acid did not have any effect on
this enzyme activity.
Virus alkaline DNase and DNA polymerase
are induced in various mammalian cells after
infection with herpes group viruses (3-5, 9, 10,
13-17, 20, 21, 26, 27). Epstein-Barr virus (EBV),
one of the herpes group viruses, is closely
associated with nasopharyngeal carcinoma
(NPC). It has been demonstrated that EBV-
specific DNase activity can be induced from
superinfected Raji cells or from iododeoxyuri-
dine-treated D98/HR-1 somatic cell hybrids (2,
8). The enzyme can be neutralized by sera of
patients with NPC, but not by sera of most
normal, healthy individuals (1). The frequency
and levels of antibody against EBV-associated
DNase in sera of patients with NPC is much
higher than those in sera of patients with other
tumors. It thus appears to be promising to use
this criterion for aiding the early diagnosis of
NPC in NPC high-risk populations and for moni-
toring the prognosis of patients being treated for
NPC. However, a major problem lies in the fact
that EBV-associated DNase obtained from su-
perinfected Raji cells is unstable, and the culti-
vation of virus and cells is relatively expensive
and technically difficult. Thus, it would be ad-
vantageous to find another source of EBV-
specific DNase.
Zur Hausen et al. (29, 30) reported a very
efficient induction of EBV in the virus-produc-
ing cell line P3HR-1 by the tumor-promoting
agent 12-O-tetradecanoyl-phorbol-13-acetate
(TPA). The sixfold increase in EBV genome
copies per P3HR-1 cell paralleled the increase in
the percentage of cells synthesizing viral capsid
antigen (VCA) (18). Datta et al. (5) took advan-
tage of this effect and found a rapid induction of
EBV-associated DNA polymerase activity in
P3HR-1 cells after treatment with TPA. The
presence of EBV-associated DNase in P3HR-1
cells has been reported by Clough (3, 4), and its
presence in superinfected Raji cells has been
found by workers in this laboratory (2). Al-
though the partial purification of this enzyme
from P3HR-1 cells has been reported (3), there is
no evidence that the enzyme studied is indeed
the same as that found in superinfected Raji
cells. This paper reports on the characterization
of DNase activity from TPA-induced P3HR-1
cells. The immunoglobulin G (IgG) fraction of
sera taken from NPC patients could neutralize
the activity of this partially purified enzyme to a
similar extent as that of the enzyme from super-
infected cells.
MATERIALS AND METHODS
Cells. The Burkitt lymphoma-derived cell line
P3HR-1 was maintained between 5 x 105 to 1 x 106
cells per ml in RPMI 1640 medium containing 10%
heat-inactivated fetal calf serum and supplemented
with 100 IU of penicillin and 100 F.g streptomycin per
ml (5). The culture and preparation of cellular extracts
of superinfected Raji cells were described by Cheng et
al. (2).
Induction with TPA. P3HR-1 cells were seeded at
106 cells per ml in culture medium. After 24 h of
cultivation at 37°C, TPA was added at a final concen-
tration of 30 ng/ml. The culture was incubated at 37°C
for the indicated periods of time. The determination of
EBV early antigen (EA)-VCA-positive cells was car-
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ried out on cell smears by the indirect immunofluores-
cence test as described by Henle and Henle (12).,
Chemicals. TPA, calf thymus DNA, bovine serum
albumin, 1-mercaptoethanol (m-ME), and phenylmeth-
ylsulfonyl fluoride (PMSF) were obtained from Sigma
Chemical Co. Phosphocellulose and DEAE-cellulose
were purchased from Whatman Inc. DNA-cellulose
was prepared by the method of Potuzak and Winters-
burger (24).
DNA substrates. Native double-stranded Escherich-
ia coli [14C]DNA was prepared from the thymine-
requiring E. coli strain ATCC 23851. The bacteria was
grown in minimal medium containing 5 ,umol of unla-
beled thymine and 125 ,Ci of [14C]thymine per liter.
The [14C]DNA was isolated by the procedure of
Marmur (19). Heated denatured [14C]DNA was pre-
pared as previously described (19).
3'-Terminally labeled activated calf thymus DNA
was prepared as described previously (7).
Enzyme assays. Alkaline DNase was measured by
the release of acid-soluble nucleotides from double-
stranded ['4C]DNA from E. coli by the method of
Hoffman and Cheng (14). One unit of enzyme was
defined as that amount which catalyzed the conversion
of 1 ,ug of double-stranded DNA to acid-soluble nucle-
otide in 10 min at 370C.
When 3'-3H-terminally labeled activated calf thy-
mus DNA was used as a substrate, the reaction
mixture of 0.2 ml contained 20 mM Tris (pH 8.0), 2
mM MgCl2, 1 mM dithiothreitol, 0.5 mg of bovine
serum albumin per ml, 0.0 to 0.3 U of DNase, and 2.4
,g of 3'-[3H]-terminally labeled activated calf thymus
DNA. The specific activity of DNA was 6 x 103 cpm/
,ug. After incubation for 30 min, the radioactive prod-
uct was determined by the same method, as described
above.
Determination of anti-EBV DNase activity was as-
sayed as described by Cheng et al. (1, 2).
DNA polymerase was assayed as described by
Weissbach et al. (28), except 150 mM KCl was added
instead of ammonium sulfate.
Preparation of IgG. Normal serum IgG and serum
IgG from patients with NPC were prepared by the
method of Cheng et al. (1).
Purification of EBV-associated DNase. All operations
were carried out at 2 to 40C unless otherwise indicated.
Step 1. Preparation of crude extract. P3HR-1 cells
(4 x 109) treated with TPA for 72 h were washed,
harvested, and suspended in 18 ml of Tris buffer (pH
7.5) containing 2mM 1-ME and 10 ±g ofPMSF per ml.
The cell suspension was frozen and thawed three
times. KCI was added to a final salt concentration of
0.4 M. The suspension was centrifuged at 12,000 rpm
for 10 min, and the supernatant was collected (super-
natant I). Twelve milliliters of the above extraction
buffer containing 0.4 M KCI was added to the precipi-
tate to extract the remaining enzyme, and the suspen-
sion was sonicated with a Branson sonifier for 1 min in
a series of four 15-s bursts separated by 1-min cooling
periods. The suspension was then centrifuged at
12,000 rpm for 10 min, and the supernatant was
collected (supernatant II). Supernatants I and II were
combined to obtain the final extract.
Step 2. DEAE-celulose chromatography. The com-
bined supernatant was dialyzed against 1 liter of buffer
A (400 mM potassium phosphate [pH 7.5] containing
20%o glycerol, 5 mM 1-ME, 2 mM MgC12, and 10 ,ug of
PMSF per ml) overnight. About 22 ml of the dialyzed
extract was loaded on a DEAE-cellulose column (24
by 8 cm) which had been preequilibrated with 300 ml
of buffer A. Fractions of 3 ml were collected, and
those containing DNase activity were pooled and
dialyzed against 2 liters of buffer B (20 mM potassium
phosphate [pH 7.51-20%'o glycerol-2 mM MgCl2-5 mM
1-ME-10 ,ug of PMSF per ml) for 18 h.
About 45 ml of the above-described dialyzed frac-
tion from the first column was loaded on a second
DEAE-cellulose column (2.4 by 11 cm) which had
been preequilibrated with 500 ml of buffer B. The
column was washed with about 45 ml of buffer B, and a
150-ml gradient of column buffers B and A was applied
to the column. Fractions of 3 ml were collected, and
those containing DNase and DNA polymerase activity
were pooled separately (Fig. 1A). Fractions containing
DNase and DNA polymerase activity were dialyzed
separately against 1 liter of buffer C (20 mM potassium
phosphate [pH 8.01-20% glycerol-2 mM MgCl,-5 mM
1-ME-10 ,ug of PMSF per ml) for 17 h.
Step 3. Phosphocellulose chromatography. Approxi-
mately 21 ml of DEAE-cellulose-purified DNase frac-
tion (Fig. 1A, fraction III) was loaded on a phospho-
cellulose column (1.4 by 8 cm) preequilibrated with
120 ml of buffer C. After washing the column, the
elution was carried out with buffer C containing a
linear gradient of potassium phosphate (pH 8.0) from
20 to 330 mM. Fractions of 2 ml were collected.
Step 4. DNA cellulose column chromatography. A
pooled phosphocellulose-purified DNase fraction (8 to
10 ml; Fig. 1B, fraction III) was dialyzed against 500
ml of buffer C for 2 h. The fraction was loaded on a
DNA-cellulose column (1 by 8 cm) equilibrated with
buffer C. After washing the column with 15 ml of
buffer C, a 50-ml gradient elution from 0 to 500 mM
potassium chloride in buffer C was carried out. Frac-
tions of 1 ml were collected. The active fractions were
pooled (Fig. 1C, fraction III) and dialyzed against
buffer C for 5 h. The preparation was made 40%o (wt/
vol) in glycerol and stored at -70°C.
The DNA polymerase-associated DNase fractions
(Fig. 1A, fraction II) were also purified separately
(Fig. 1).
RESULTS
Induction of alkaline DNase activity after TPA
treatment. Figure 2A shows the kinetics of in-
duction of alkaline DNase activity in extracts of
TPA-treated and untreated P3HR-1 cells. The
induction started from day 1 of treatment and
was maintained at the elevated level. Part of this
alkaline DNase activity in the crude extract of
P3HR-1 cells can be neutralized by NPC serum.
Interestingly, there is only a little change in non-
neutralizable DNase activity. Under these con-
ditions, Raji cells, a nonproducer cell line, do
not show any increase in alkaline DNase activi-
ty.
With the increase in alkaline DNase activity
there was also an increase in the number of EA-
VCA-positive cells (Fig. 2B). The maximum
number of EA-VCA-positive cells occurred after

























FIG. 1. Chromatography of extracts from TPA-treated P3HR-1 cells. Details of the procedures for DEAE
cellulose (A), phosphocellulose (B), and DNA-cellulose (C) chromatography are described in the text.
line DNase activity and the percentage of EA-
VCA-positive cells in nontreated cultures of
P3HR-1 cells remained the same throughout this
course. Thus, the parallel increase in the alka-
line DNase activity and EA-VCA-positive cells
suggests that the enzyme induced is most proba-
bly associated with virus replication.
Identification of virus-associated DNase activi-
ty. About 35 to 45% of the total DNase activity
(Fig. 1A, fraction I) of crude extract was not
adsorbed to the DEAE-cellulose column. The
unadsorbed fraction had a very high level of
DNA polymerase activity; this nonadhering ac-
tivity has been shown to have the characteristics
of host ,B-polymerase (28), such as N-ethylmalei-
mide resistance and inhibition by high salt (data
not shown). The adsorbed DNases are eluted
into two distinct peaks (Fig. 1A, fractions II and
III). Fraction II DNase, which was eluted at 100
mM potassium phosphate, contained high levels
of DNA polymerase activity. The fraction III
DNase was bound more tightly and was eluted at
200 to 250 mM potassium phosphate. No detect-
able DNA polymerase activity was observed in
the peak fractions of fraction III.
When fractions II and III from the DEAE-
cellulose column were rechromatographed sepa-
rately on a phosphocellulose column, fraction II,
which was eluted at 100 mM potassium phos-
phate (Fig. 1B, fraction II), had both DNase and
DNA polymerase activities. However, fraction
III, which was eluted at 200 mM potassium
phosphate (Fig. 1B, fraction III) did not contain
any detectable DNA polymerase.
Further rechromatography of fractions II and
III (Fig. 1C) on the DNA-cellulose column re-
sulted in the profile shown in Fig. 1C, fractions
II and III. Fraction CII, which was eluted at 280
mM potassium chloride, still contained DNA
polymerase activity, but interestingly, peak frac-
tions of these two enzymes did not coincide and
there was a small reproducible shoulder on the
DNA polymerase activity profile. Fraction CIII
contained only DNase activity and was eluted as
one sharp peak at 450 mM potassium chloride.
The DNases eluted in fractions CII and CIII had
VOL. 44, 1982













1 2 3 4 5
Days after TPA addition
FIG. 2. Kinetics of induction of EBV-associated
DNase (A) and VCA (B) in EBV-carrying lymphoblas-
toid cells upon treatment with TPA. Cells grown in
suspension (106 cells per ml) were treated with TPA at
a concentration of 30 ng/ml. On the indicated days,
cells were processed as described in the text and
assayed for DNase activity (A) and VCA (B). 0,
Untreated P3HR-1 cells; 0, TPA-treated P3HR-1
cells; A, untreated Raji cells; O, TPA-treated Raji
cells. The non-neutralizable DNase activity (U) from
TPA-treated P3HR-1 cells is described as the differ-
ence between total DNase and neutralized DNase. For
the neutralization assay, the extract was treated with
NPC serum for 20 min at room temperature and then
used for assay.
specific activities of 61.5 and 480 U/mg of pro-
tein, respectively.
Neutralizing activity of serum from patients
with NPC on DNases. Reports from this labora-
tory (1) have shown that DNase activity in
superinfected Raji cells could be neutralized by
sera ofNPC patients. About 40 to 45% of DNase
activity of crude extract from P3HR-1 cells after
TPA treatment was neutralized by sera of NPC
patients (more than 10 patient sera tested, Fig.
3). After DNA-cellulose purification, almost
90% of the activity (fraction CIII) could be
neutralized. In contrast, fractions Al and CII
showed no neutralization with the serum.
Identical results were obtained when IgG was
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FIG. 3. Neutralizing activity of NPC serum on
DNases. The method of neutralization of DNase activ-
ity is described in the legend to Fig. 2. Native E. coli
DNA was used as the substrate. DNase preparations
were from TPA-treated P3HR-1 cell crude extract (A),
fraction I from DEAE cellulose (O), and DNA-cellu-
lose-purified fraction II (0), and DNA-cellulose-puri-
fied fraction III (0).
put into the same test (Fig. 4). Fraction CIII was
almost 90% neutralized. This result is similar to
those obtained with the extract from superin-
fected Raji cells, whereas IgG from normal
individuals was inactive.
Utilization of substrates. All three DNase frac-
tions could utilize native and denatured DNAs
from E. coli and 3'-terminally labeled activated
DNA from calf thymus in different degrees (Ta-










FIG. 4. Neutralizing activity of IgG on DNases.
Preparations of IgG and the neutralization of DNases
are described in the text. IgG from normal serum was
added to the superinfected Raji cell extract (A) and
DNA-cellulose-purified DNase offraction III (A). IgG
from sera of patients with NPC was added to the
superinfected Raji cell extract (0) and the DNA-




TABLE 1. Utilization of substrate by different
DNase fractions
Relative activity of DNase
Substrate (%) in fractiona:
Al CII CIII
Native E. coli DNA 100 100 100
Denatured E. coli 125 170 76
DNA
3'-Terminally labeled 59 100 22
calf thymus DNA
a Standard enzyme assay and the preparation of
different substrates are described in the text. Fraction
II and III DNases were DNA-cellulose column puri-
fied; 0.2 U of DNase of different fractions (Fig. 1A,
fraction I, and 1C, fractions II and III) were used.
and CII utilize denatured E. coli DNA more
efficiently than fraction CIII as compared with
native E. coli DNA. In contrast, when 3'-termi-
nally labeled activated calf thymus DNA was
used as the substrate, fraction CII was found to
be very efficient, whereas fractions Al and CIII
represented 50 and 22%, respectively, of the
activity as compared with fraction CII. It is thus
evident that fraction CIII DNase has clearly
different substrate requirements than other two
DNase fractions.
Effect of salt. There were not many differential
effects of salt on three DNase fractions when 3'-
terminally labeled activated calf thymus DNA
was used as the substrate (Fig. 5A). However,
potassium chloride exerted a marked differential
effect on three DNases when native E. coli DNA
was used as a substrate. The DNA-cellulose-
purified fractions were very sensitive to high salt
concentrations. Fractions II and III were 50%o
inhibited at 45 and 100 mM salt concentrations,
respectively, whereas the 50% infective dose of
fraction I DNases was shown to be more than
200 mM. This characteristic, therefore, distin-
guishes three fractions from each other.
Effect of PFA on DNase activity. It has been
reported that herpes simplex virus-specified
DNA polymerase and its associated exonuclease
are inhibited by phosphonoacetic acid (PAA)
and phosphonoformic acid (PFA) (17, 22).
Therefore, it was of interest to check the effect
of PAA and PFA on the purified DNases. In our
system, none of the DNases were affected by
PFA. This was observed both when E. coli DNA
and 3'-terminally labeled activated calf thymus
DNA was used as substrate (data not shown).
Properties of DNA polymerase activity. Since
reports on the effect of salt and pyrophosphate
analogs on EBV-associated DNA polymerase
are conflicting (5, 10, 21), it is important to
reexamine this issue in our system. We have
shown (Fig. 1C, fraction II) that a reproducibly
small shoulder is observed in the DNA polymer-
ase elution profile. This result led us to believe
that the activity profile might represent a mix-
ture of two activities. As pyrophosphate analogs
and high salts are the two widely used reagents
known to differentiate between various DNA
polymerases (5, 17, 22), the effect of these
reagents were checked on these two putatively
different activities. There was a definite differ-
ence in the concentration-dependent salt activa-
tion pattern with respect to the fractions used for
assay (Fig. 6A). Fractions pooled from the left
side of the profile (Fig. 1C, fraction Ila) respond-
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FIG. 5. Effect of potassium chloride on DNase activities from different fractions with 3H-terminally labeled
activated calf thymus DNA (A) and E. coli "C-labeled native DNA (B) as substrates. Fractions I (O), CII (0),
and CIII (0) were assayed with the indicated concentrations of salt.
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FIG. 6. Effect of ammonium sulfate (A) and phos-
phonoformic acid (B) on DNase-associated DNA poly-
merase fractions CIIa and Cllb. DNA polymerase
from fractions CIla (0) and CIIb (0) were assayed as
described in the text.
pooled from the right side (Fig. 1C, fraction IIb).
However, when increasing amounts of PFA
were used in the reaction mixture (Fig. 6B),
fractions pooled from the left side of the profile
responded more to inhibition than the fractions
pooled from the right side. Implications of these
results will be made in the discussion.
DISCUSSION
We have reported on the identification and
characterization of a new alkaline DNase activi-
ty induced after treatment ofthe EBV-producing
cell line P3HR-1 with TPA. The inability of TPA
to induce a similar kind of activity in non-virus-
producing Raji cells supports the notion that the
enzyme is associated with the virus replication
cycle and is not due to artifacts of chemical
treatment. The partially purified activity de-
scribed here is devoid of any detectable DNA
polymerase activity and is thus clearly different
from the viral DNA polymerase-associated nu-
clease activity, as has been reported in other
systems (17). In fact, the activity never co-
chromatographed with viral DNA polymerase
activity at any step of purification, as has been
described elsewhere (3).
The DNase activity can be neutralized
with sera obtained from patients with NPC.
Moreover, the finding that purified activity is
also neutralizable with purified IgG preparations
from the sera ofNPC patients and not with those
from normal individuals points to the fact that
the neutralizing activity of NPC serum is an
antigen-antibody reaction and is not due to some
nonspecific factor(s) in the serum. The neutral-
ization curve of purified fraction (Fig. 1C, frac-
tion III) is very similar to that of the DNase
activity of superinfected Raji cells (1; Fig. 4).
There are several reasons to believe that the
EBV-associated DNase activity described here
is not due to mycoplasma DNases (25). First, the
induction of activity in P3HR-1 cells by TPA
with respect to identically subcultured P3HR-1
cells in the absence of TPA makes it unlikely
(Fig. 2A). Second, the activity is similar to that
found in superinfected Raji cells as measured by
neutralization with IgG. Third, the activity can
be neutralized by sera of patients with NPC, but
not by that of most healthy individuals.
Our results on the substrate specificity of the
enzyme differs from a previous report (3). These
differences may be due to the use of different
fractions from the DEAE-cellulose column.
When 3'-terminally labeled activated calf thy-
mus DNA was used, the enzyme showed a
preference similar to that of the DNase found in
EBV-superinfected Raji cells (unpublished
data).
The EBV DNA polymerase-associated DNase
activity described here (Fig. 1C, fraction II) is
different from that of herpes simplex virus DNA
polymerase-associated exonuclease (17) by vir-
tue of the fact that, unlike herpes simplex virus
DNA polymerase associated-exonuclease (7,
22), this activity is inhibited by salt (Fig. 5) and
is insensitive to PFA (data not shown). In this
respect, the activity is somewhat similar to that
previously reported in a herpes simplex virus
system (14).
The other DNase activity which always co-
purified with the DNA polymerase (Fig. 1C,
fraction III) was insensitive to sera of NPC
patients. At this point, therefore, we are unable
to predict anything about this nuclease. To our
surprise, however, the DNA polymerase activi-
ty(s) of this peak(s) behaves differentially with
respect to salt and PFA (Fig. 6), probably owing
to the fact that both EBV-associated DNA poly-
merase and another unidentified polymerase ac-
tivity are coeluted as mixtures. The left side of
the peak (Fig. 1C, fraction Ia), because of a high
EBV-enzyme content, behaves more like EBV-
associated polymerase in terms of salt activation
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and PFA sensitivity (5, 6). Further work is
obviously necessary to settle this issue.
Recently, Graw et al. (11) reported the isola-
tion of an ATP-dependent DNase from lympho-
cyte. Though P3HR-1 is a kind of lymphocyte,
we could not find any ATP-dependent DNase
activity in our preparations, possibly owing to
the fact that the lymphocytes are diverse in
nature and it thus becomes difficult to extend the
findings from one type of cell to another (23).
Further studies on the properties of DNases
from TPA-treated P3HR-1 cells are under way.
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